Summary
Methylglyoxal (MG) is a toxic byproduct of glycolysis that damages DNA and proteins ultimately leading to cell death. Protection from MG is often conferred by a glutathione-dependent glyoxalase pathway. However, glutathione is absent from the low-GC Gram-positive Firmicutes, such as Bacillus subtilis. The identification of bacillithiol (BSH) as the major low molecular weight thiol in the Firmicutes raises the possibility that BSH is involved in MG detoxification. Here, we demonstrate that MG can rapidly and specifically deplete BSH in cells, and we identify both BSH-dependent and BSH-independent MG resistance pathways. The BSH-dependent pathway utilizes glyoxalase I (GlxA, formerly YwbC) and glyoxalase II (GlxB, formerly YurT) to convert MG to D-lactate. The critical step in this pathway is the activation of the KhtSTU K+ efflux pump by the S-lactoyl-BSH intermediate, which leads to cytoplasmic acidification. We show that cytoplasmic acidification is both necessary and sufficient for maximal protection from MG. Two additional MG detoxification pathways operate independent of BSH. The first involves three enzymes (YdeA, YraA and YfkM) which are predicted to be homologues of glyoxalase III that converts MG to D-lactate, and the second involves YhdN, previously shown to be a broad specificity aldo-keto reductase that converts MG to acetol.
Keywords: Bacillus subtilis, bacillithiol, methylglyoxal, glyoxalase, electrophile
Introduction
Methylglyoxal (MG) is a toxic, endogenous byproduct of glycolysis (Ackerman et al., 1974). It is synthesized by methylglyoxal synthase (MGS) under conditions of carbon excess or phosphate limitation, which lead to an imbalance between the rate of carbon acquisition and the lower segment of glycolysis (Booth et al., 2003). The main role of MGS is to restore inorganic phosphate levels. Bacteria can also encounter MG in the environment (Booth et al., 2003; Landmann et al., 2011). MG has been found in many food and beverages and thus members of the gut microbiota may be regularly exposed to MG (Griffith and Hammond, 1989). In addition, MG is produced by macrophages as part of the response to invasion by pathogenic bacteria. As an electrophile, MG can modify guanine bases in DNA, leading to DNA damage and an increased rate of mutation (Papoulis et al., 1995). Accumulation of MG is also associated with an increase in the rate of “persister” cell formation in E. coli (Girgis et al., 2012). Furthermore, MG can react with arginine, lysine, and cysteine residues in proteins resulting in protein inactivation (Leoncini et al., 1980).
The major mechanism of protection from MG in E. coli is dependent on the highly conserved glyoxalase system and the low molecular weight (LMW) thiol glutathione (GSH) (Ferguson and Booth, 1998). Exposure to MG leads to the spontaneous formation of the GSH-hemithioacetal (HTA) adduct. Glyoxalase I (GlxI) catalyzes the formation of S-lactoyl glutathione (S-lactoyl-GSH) from HTA (MacLean et al., 1998). Recent reports in E. coli suggest that glyoxalase I expression is upregulated in response to MG as a result of readthrough transcription from the nemRA operon (Lee et al., 2013; Ozyamak et al., 2013). The S-lactoyl-GSH intermediate is critical to protection from MG stress as it is required for the full activation of the KefGB K+ efflux pump (Ozyamak et al., 2010). The H+ influx that accompanies KefGB-mediated K+ efflux leads to cytoplasmic acidification, and this acidification is sufficient to confer resistance to MG exposure (Ferguson et al., 1993). Finally, glyoxalase II converts S-lactoyl-GSH to D-lactate and regenerates GSH (Ozyamak et al., 2010). In addition, GSH independent pathways have been identified in E. coli. HchA (glyoxalase III), originally identified as a heat shock protein with weak chaperone activity, converts MG directly to D-lactate (Subedi et al., 2011). Also, a number of low specificity aldo-keto reductases may make minor contributions to MG resistance (Ko et al., 2005).
Bacillus subtilis mounts a transcriptional response to alleviate the cell damage caused by MG exposure (Nguyen et al., 2009). For example, the SOS regulon is induced, possibly in response to the modification of DNA by MG. Depletion of the LMW thiol pool by MG leads to an imbalance in thiol-redox homeostasis. As a result, the Spx (thiol homeostasis), CtsR (misfolded protein response), and CymR (cysteine formation) regulons are induced. The Spx regulon includes ytpQ, which has been implicated in both iron homeostasis and prevention of oxidative protein damage after exposure to MG (Zuber et al., 2011).
Until recently, the major LMW thiol in the low-GC Gram-positive bacteria (Firmicutes) was assumed to be cysteine or coenzyme A (CoA). In 2007, bacillithiol (BSH) was identified as the major LMW thiol in B. subtilis. We originally detected BSH in mixed disulfides formed by the organic peroxide sensing transcription regulator, OhrR, under conditions of oxidative stress (Lee et al., 2007). Since the identification of BSH in B. subtilis, a bioinformatic survey suggests that BSH is widely distributed among the low-GC Gram-positive bacteria, whose members include B. anthracis, Staphylococcus aureus, and Listeria monocytogenes (Newton et al., 2009). Structurally, BSH is comprised of L-cysteine linked to a glucosamine and malic acid (Newton et al., 2009). BSH is similar to another alternative LMW thiol found in Gram positive bacteria, mycothiol, but is considerably different from the GSH tripeptide. Organisms containing BSH contain BSH-dependent enzymes analogous to their GSH-dependent counterparts. To date, the best characterized is the BSH-dependent thiol transferase FosB involved in resistance to fosfomycin (Gaballa et al., 2010; Roberts et al., 2013; Thompson et al., 2013), which is structurally and functionally analogous to its GSH-dependent counterpart, FosA (Bernat et al., 1997).
We postulated that BSH serves a protective function against MG stress in a manner functionally analogous to GSH. The first hint came from the observation that the gene encoding methylglyoxal synthase (MGS), mgsA, shares an operon with the genes encoding the first two enzymes in the BSH biosynthetic pathway, bshA and bshB1 (Gaballa et al., 2010). Furthermore, the genes required for BSH synthesis are members of the Spx regulon (Rochat et al., 2012; Gaballa et al., 2013), which is induced in response to MG (Nguyen et al., 2009). Consistent with a role in MG resistance, strains lacking BSH are more sensitive to exogenous MG than wild-type (Gaballa et al., 2010).
In this work, we identify both BSH-dependent and BSH-independent pathways for MG detoxification in B. subtilis (Fig. 1). Our genetic studies reveal two BSH-dependent enzymes, glyoxalase I (YwbC; renamed GlxA) and glyoxalase II (YurT; renamed GlxB), that convert MG to D-lactate. The critical step in this pathway is the activation of the KhtSTU K+ efflux pump by the production of S-lactoyl-BSH, which leads to cytoplasmic acidification. In addition, we have identified two BSH-independent MG detoxification pathways. The first involves YdeA, YraA, and YfkM, structural homologs of E. coli glyoxalase III (HchA), and the second involves YhdN, a broad specificity aldo-keto reductase that converts MG to acetol.
Figure 1. Summary of BSH-dependent and BSH-independent MG detoxification pathways.
Proteins demonstrated as important for MG detoxification in vivo by this study are highlighted in bold. For proteins that have been renamed, the previous name is given below the new name in parentheses.
Results and Discussion
Determination of the BSH-dependent methylglyoxal detoxification pathway
Previous studies showed that BSH null cells are more sensitive to MG than wild-type cells, consistent with a possible role for BSH in enzymatic MG detoxification (Gaballa et al., 2010). Given that the major mechanism of MG detoxification in many organisms relies on the glyoxalase I/II pathway, we searched the B. subtilis genome for putative glyoxalase enzymes. We previously identified ywbC and yurT as candidates for glyoxalase I and glyoxalase II, respectively (Nguyen et al., 2009). Based on the results reported herein, we rename YwbC to GlxA (glyoxalase A) and YurT to GlxB (glyoxalase B) to reflect their function in MG resistance.
Since GlxA is predicted to catalyze the conversion of the hemithioacetal (HTA) adduct to S-lactoyl-BSH in the first step in MG detoxification, we predicted that a glxA mutant would be more sensitive to MG than wild-type. Indeed, in a glxA mutant we observe an increase in MG sensitivity equal to what is observed with a BSH null strain (bshC) by disk diffusion assays (Fig. 2). MG sensitivity of the glxA bshC double mutant was comparable to the glxA or bshC single mutants, suggesting that GlxA and BSH are in the same pathway. This supports the assignment of GlxA as a novel, BSH-dependent ortholog of glyoxalase I. Moreover, these results indicate that GlxA is required for the major BSH-dependent pathway for MG resistance.
Figure 2. Determination of BSH-dependent MG detoxification pathway.
Susceptibility of wild-type and mutant strains to MG (27.5 mmol) was tested by disk diffusion assay. The zone of inhibition is expressed as the diameter of the clearance zone in millimeters. The mean and standard deviation from at least three biological replicates is shown.
We next tested GlxB, the putative glyoxalase II enzyme, for a role in MG resistance. Glyoxalase II converts S-lactoyl-BSH to D-lactate that can either enter the TCA cycle or be excreted from the cell. In contrast with the glxA mutant, a glxB mutant has a small increase in MG resistance (Fig. 2). This increase in resistance may be due to an accumulation of the S-lactoyl intermediate, which by analogy with the results from E. coli (Ozyamak et al., 2010), could result in greater cytoplasmic acidification in response to MG. Consistent with this hypothesis, the observed increase in MG resistance in the glxB mutant is dependent on BSH: the MG sensitivity of a glxB bshC double mutant is comparable to the bshC single mutant (Fig. 2).
In E. coli, production of S-lactoyl-GSH by glyoxalase I leads to activation of the protective KefGB and KefFC K+ efflux systems (Ferguson et al., 1993). Activation of the KefGB and KefFC systems leads to cytoplasmic acidification, which is critical for survival of MG stress. We sought to identify candidates for K+ efflux systems that may serve a similar function in B. subtilis. B. subtilis possesses a K+ efflux pump encoded by the khtST yhaU operon that has been well characterized in vitro (Fujisawa et al., 2007). YhaU is a member of the cation/anion antiporter 2 (CPA2) family of transporters, whose members also include KefGB and KefFC, while KhtS and KhtT are ancillary proteins that modulate YhaU function (Fujisawa and Wada, 2004). We propose renaming YhaU to KhtU, adopting a similar naming convention to its ancillary proteins KhtS and KhtT.
We used a genetic approach to determine if KhtU plays a role in MG resistance. We observed that the khtU mutant is more sensitive to MG than wild-type (Fig. 2), consistent with the hypothesis that the KhtU K+ efflux pump is involved in MG resistance. Moreover, the khtU bshC double mutant is no more sensitive than the khtU single mutant. This suggests that activation of KhtU relies on BSH, and further suggests that this activation is the dominant, or perhaps only, contribution of BSH to MG resistance.
The glyoxalase I/II pathway may contribute to MG resistance by either or both of two mechanisms. First, the conversion of MG to S-lactoyl-BSH may activate the KhtU K+ efflux pump leading to cytoplasmic acidification. Second, the enzymatic removal of MG by GlxA may detoxify the cytosol. To address the relative contributions of these pathways, we measured the MG sensitivity of a khtU glxB mutant. This mutant is predicted to accumulate S-lactoyl-BSH, but is missing the KhtU K+ efflux system. If the conversion of MG to S-lactoyl-BSH is sufficient for protection, we predict that the khtU glxB double mutant would be as resistant to MG as the glxB single mutant. However, we observed that the khtU glxB double mutant is as sensitive to MG as the khtU single mutant, suggesting that conversion of MG to S-lactoyl-BSH is insufficient for MG resistance under these conditions (Fig. 2).
To further investigate the role of the BSH-dependent pathway in MG detoxification, we measured intracellular BSH levels after MG treatment. In wild-type cells, BSH concentrations increase at higher cell densities with typically 2–4 µmol per gm dry weight during mid-logarithmic phase (corresponding to ~0.7–1.3 mM cytosolic BSH; see Experimental Procedures) (Fig. 3). BSH levels are rapidly depleted (~90% lower than untreated cells) upon exposure to 1 mM MG and this depletion occurs within 10–15 min. of treatment. Similar results are seen in a bshB2 mutant that lacks an enzyme that can deacetylate the BSH precursor GlcNAc-Mal (Gaballa et al., 2010), and may also serve as a bacillithiol-S-conjugate amidase (BCA) (Fang et al., 2013). The bshB2 null strain still produces near wild-type levels of BSH (Fig. 3B), due to the activity of the BshB1 deacetylase, as shown previously (Gaballa et al., 2010). Over the course of several hours, BSH recovers to levels comparable to those in the untreated cells at the same growth phase. We hypothesized that the recovery of BSH might be due to the activity of GlxB, which converts S-lactoyl-BSH to D-lactate, thereby recycling BSH. Consistent with this hypothesis, BSH levels did not recover after MG treatment in the glxB mutant strain over the time course of the experiment (Fig. 3D). In cells lacking GlxA, BSH levels also recover after MG addition (Fig. 3C). In the absence of GlxA, the product of the spontaneous reaction between BSH and MG (the HTA adduct) cannot be converted to S-lactoyl-BSH. Since the formation of the HTA adduct is reversible, we propose that the observed recovery of BSH in the glxA mutant is due to alternative MG detoxification pathways as described below.
Figure 3. Recovery of BSH after MG challenge requires GlxB.
Cellular BSH concentration as a function of time after MG addition in wild-type (A), bshB2 (B), glxA(C) and glxB (D) mutant strains. Cells were challenged with 1 mM MG (time 0) and harvested at the indicated time points. Representative growth curves are shown for cells grown in the absence (grey squares) and presence (grey circles) of MG. Cellular BSH levels in the absence (black squares) and presence (black circles) of MG were quantified by HPLC after derivatization with monobromobimane. The average and standard deviation calculated from three independent experiments are shown.
Methylglyoxal induces BSH-dependent cytoplasmic acidification
Studies from the Booth lab demonstrated that activation of the Kef K+ efflux systems in response to MG leads to cytoplasmic acidification, which is required for MG resistance (Ferguson et al., 1993). To determine if KhtSTU leads to cytoplasmic acidification, we monitored the intracellular pH (pHi) of cells treated with MG using the pH sensitive GFP reporter pGFPmut3 (Kitko et al., 2009). In the absence of MG, wild-type, bshCglxB and khtU strains all had an intracellular pH (pHi) near 7.7 (Fig. 4), consistent with previously reported values (Kitko et al., 2009). Upon treatment with 1.5 mM MG, the pHi of the wild-type decreased ~0.4 pH units to ~7.3 (Fig. 4A). Cytoplasmic acidification is dependent on both BSH and KhtU, since the pHi of bshC and khtU mutants remained at 7.7 even after MG treatment (Fig. 4B, D). We also examined the pHi of the glxB mutant as previous studies in E. coli have shown that glyoxalase II mutants have a greater pHi decrease in response to MG due to an accumulation of S-lactoyl-GSH (Ozyamak et al., 2010). However, we did not observe a similarly increased response (Fig. 4C). These data support a model in which MG results in cytoplasmic acidification mediated by the KhtU K+ efflux pump. Since acidification is dependent on BSH (but not on GlxB), we suggest that S-lactoyl-BSH may serve to gate the KhtU K+ efflux system just as S-lactoyl-GSH does for E. coli.
Figure 4. MG exposure leads to BSH and KhaSTU-dependent cytoplasmic acidification.
Intracellular pH values for wild-type (A), bshC (B), glxB (C), and khtU (D) strains in the presence of MG. 1.5 mM MG was added at time 0. The averages and standard deviation calculated from three independent experiments are shown.
Maintenance of appropriate intracellular pH and cell turgor pressure by regulation of K+ levels is critical to cell viability (Booth, 1985). Both B. subtilis KhtU and the E. coli Kef channel belong to a family of cation/proton antiporters (CPA2) that is characterized by the ability to couple cation efflux with proton influx and the presence of a K+ transport nucleotide binding (KTN) domain, which is responsible for the cytoplasmic regulation of K+ channels and transport. In addition to activation by S-lactoyl-GSH, GSH itself inhibits Kef function. In the absence of GSH, the Kef channel has an intermediate level of activity between the fully closed and open states (Elmore et al., 1990). Structural and biochemical studies have revealed that GSH binds to a cleft formed by the two KTN domains of the KefFC dimer rendering it inactive by stabilizing an interaction between the two monomers (Roosild et al., 2010). The structure of KefFC bound to a GSH adduct suggests that S-lactoyl-GSH (leading to activation) and GSH (leading to inhibition) likely compete for the same binding site.
Our data suggest that BSH may serve a similar function in the inhibition of KhtU since a khtU mutant is more sensitive to MG than a BSH null strain. In the absence of BSH, the KhtU channel may be partially active prior to MG addition offering a small level of additional protection from MG through a slight decrease in cytoplasmic pH, whereas a strain lacking KhtU is completely unable to respond to MG. However, we were unable to observe differences in the pHi of a BSH null strain compared to wild-type. Further studies on the possible function of KhtU as a BSH-gated K+ efflux channel should provide additional insight into the regulation of intracellular K+ levels.
Cytoplasmic acidification is sufficient for protection of cells from MG even in the absence of BSH
We next sought to determine if cytoplasmic acidification is sufficient to protect B. subtilis from MG. To address this question, we treated cells with a concentration of sodium benzoate determined, in preliminary experiments, to cause a ~0.4 unit drop in pH (Kitko et al., 2009, and data not shown). Mid-logarithmic phase cells were treated with 3 mM MG for 5 min before addition of 30 mM sodium benzoate. Upon MG addition, we observed a 2-fold decrease in cell viability (colony forming units) for wild-type cells and a 4–10 fold decrease in viability for bshC and khtU mutants, which provides further evidence for the role of BSH and KhtU in MG resistance (Fig. 5A, B, C). Addition of sodium benzoate alone had no effect on cell viability. When sodium benzoate was added 5 min. after MG addition, wild-type cells were protected from MG toxicity (Fig. 5A). Importantly, bshC and khtU strains, which are unable to decrease intracellular pH in response to MG, were also protected from MG by addition of sodium benzoate (Fig. 5B, C). These data support the inference noted above that cytoplasmic acidification is the primary pathway of BSH-dependent MG resistance.
Figure 5. Cytoplasmic acidification is sufficient for protection from MG exposure.
Wild-type (A), bshC (B), and khaU (C) strains grown in modified M63 media buffered to pH 7.0 with 50 mM MOPS were challenged at time 0 with 3 mM MG. After 5 minutes of MG treatment, 30 mM of sodium benzoate was added. Aliquots were removed at various times after MG addition, then diluted, spread on LB plates, and incubated at 37°C overnight. Percent survival was calculated as the number of colonies that grew after treatment divided by the number of colonies that grew in the absence of treatment multiplied by 100.
Cytoplasmic acidification is the dominant role of BSH in MG resistance
Protection from MG by the glyoxalase system can be achieved by two mechanisms: (1) removal of MG by formation of the hemithioacetal and conversion to D-lactate by glyoxalase I and II and (2) cytoplasmic acidification through activation of K+ efflux channels by S-lactoyl conjugates. Consistent with previous work in E. coli, we demonstrate that cytoplasmic acidification is the major glyoxalase dependent mechanism of MG protection in B. subtilis. The intracellular concentration of MG in B. subtilis can reach levels as high as 0.3 mM (Landmann et al., 2011), while BSH concentrations range from 0.3–3 mM during growth (Fig. 3). Since BSH is required for multiple cellular functions, the BSH pool may be substantially reduced under conditions of maximal MG production, leaving the cell vulnerable to additional insults. Thus, the cell may benefit from a rapid mechanism to protect itself from MG while maintaining a sufficient BSH pool. Consistent with models developed for MG resistance in E. coli (Ozyamak et al., 2010), we therefore suggest that cytoplasmic acidification through activation of K+ channels offers a more rapid means of protection than can be provided by the enzymatic conversion of MG to D-lactate by glyoxalase I and II. Ultimately, the combined actions of glyoxalase I and II serve to replenish the BSH pool, although the results in Fig. 3 suggest that this may be a relatively slow process. The mechanism of protection conferred by cytoplasmic acidification is poorly understood. However, it is suggested that the main role of cytoplasmic acidification is to protect cells from MG-induced DNA damage (Ferguson et al., 2000).
Determination of BSH-independent MG detoxification pathways
Next, we investigated candidate BSH-independent pathways of MG resistance in B. subtilis. We first searched for a B. subtilis homolog of glyoxalase III (HchA in E. coli), which converts MG directly to D-lactate (Subedi et al., 2011). Using the Phyre2 structural homology search program (Kelley and Sternberg, 2009), we identified YdeA as a possible structural homolog of E. coli glyoxalase III, a DJ-1/PfpI family protein. In addition, a previous study showed that the transcription of two additional DJ-1/PfpI family proteins, YraA and YfkM, is increased upon MG exposure and that a yraA yfkM double mutant is more sensitive to MG than wild-type (Nguyen et al., 2009). Indeed, consistent with previous results, yraA and yfkM single mutants are no more sensitive to MG than wild-type, whereas a yraA yfkM double mutant is more sensitive. A ydeA mutant was slightly more sensitive to MG than wild-type, which suggests that YdeA is also involved in MG detoxification in B. subtilis (Fig. 6A). ydeA bshC and yraA yfkM bshC mutants displayed increased sensitivity when compared to the single mutants, consistent with the notion that YdeA, YraA, and YfkM represent BSH-independent MG detoxification enzymes orthologous to E. coli glyoxalase III.
Figure 6. Contribution BSH independent pathways to MG resistance.
Susceptibility of (A) putative glyoxalase III and (B) aldo-keto reductase mutant strains to MG (27.5 mmol) was tested by disk diffusion assay. The zone of inhibition is expressed as the diameter of the clearance zone in millimeters. The mean and standard deviation from at least three biological replicates is shown.
Thiol-independent MG detoxification in E. coli can also be carried out by broad specificity aldo-keto reductases, which comprise a large superfamily of NADPH-dependent enzymes that can reduce aldehydes and ketones (Ko et al., 2005). An interesting candidate for this function in B. subtilis is AdhA, an aldehyde dehydrogenase whose expression is induced by MG (Nguyen et al., 2009). However, an adhA mutant does not have an increased sensitivity to MG (V. Patel and JDH, unpublished data).
A second candidate for a BSH-independent detoxification mechanism is the YhdN broad specificity aldo-keto reductase that has been shown previously to reduce MG to acetol in vitro (Ehrensberger and Wilson, 2004). The yhdN gene is a member of the large σB-dependent stress and stationary phase regulon (Petersohn et al., 1999). Expression of the σB regulon is induced under various stress conditions including exposure to heat, ethanol, high salt, starvation, or oxidative stress. Thus, expression of YhdN may occur in response to elevated levels of oxidative protein damage caused by MG. A yhdN null mutant has increased sensitivity to MG compared to wild-type and is even more sensitive than a BSH null strain (Fig. 6B). This suggests that YhdN is involved in MG resistance in vivo and may contribute to a larger degree than the BSH-dependent pathway under these conditions.
In E. coli, four different broad specificity aldo-keto reductases (AKRs), YafB, YqhE, YeaE and YghZ, have been implicated in MG detoxification, but their aggregate contribution to MG resistance has not been assessed (Ko et al., 2005). We tested the contribution of five additional putative B. subtilis aldo-keto reductases (YvgN, YccK YqkF, YrpG, and IolS) to MG resistance. None of corresponding null mutations (alone or in combination with a yhdN null mutation) increased MG sensitivity, suggesting that YhdN is the major aldo-keto reductase responsible for MG detoxification. Structural studies of the AKRs suggest that the substrate specificity is a result of differences in the active site architecture of each enzyme (Ehrensberger and Wilson, 2004; Marquardt et al., 2005). Interestingly, YvgN has glyoxal/methylglyoxal reductase activity in vitro (Sakai et al., 2001), yet deletion of yvgN has no effect on MG sensitivity. This may be explained, in part, by the lower catalytic efficiency of YvgN (kcat/KM of 1.58 s−1 mM−1) (Lei et al., 2009) when compared to YhdN (kcat/KM of 7.20 s−1 mM−1) (Ehrensberger and Wilson, 2004). Our results indicate that, in B. subtilis, the yhdN bshC double mutant was more sensitive to MG than either single mutant, and the yhdN ydeA bshC triple mutant was more sensitive than the yhdN bshC double mutant, consistent with a model in which BSH-dependent activation of the KhtU transporter, the YhdN aldo-keto reductase, and the GlxC enyzmes all contribute to distinct MG detoxification pathways (Fig. 1).
Conclusions
This study provides insight into the role of the low molecular weight thiol BSH in MG resistance in B. subtilis and additionally defines two BSH-independent pathways of MG detoxification. The BSH-dependent glyoxalase I/II system (GlxA and GlxB) confers protection against MG primarily through cytoplasmic acidification resulting from the activation of the KhtSTU K+ efflux pump and secondarily by converting MG to D-lactate. We also identify three proteins (YdeA, YfkM, and YraA) as candidate glyoxalase III enzymes, capable of converting MG to D-lactate in a BSH-independent manner, and demonstrate genetically that all three contribute to survival in cells challenged with exogenous MG. The third means of MG detoxification relies on the YhdN aldo-keto reductase, which converts MG to acetol. This is the single most important pathway, as judged by the level of sensitivity to MG, under conditions of excess MG in the environment. The relative contributions of these three pathways to MG produced as a natural byproduct of metabolism awaits further study. We do not exclude the possibility that there may be additional MG detoxification pathways in B. subtilis, perhaps involving alcohol dehydrogenases or aldehyde reductase which play a minor role in MG resistance in E. coli (Misra et al., 1996). While there are many similarities between the E. coli and B. subtilis detoxification systems, the nature of the precise interactions between BSH and BSH-interacting proteins will be of interest given the differences between the structures of GSH and BSH.
Experimental Procedures
Bacterial strains, plasmids, and growth conditions
Strains and plasmids used in this study are listed in Table 1. Bacteria were grown in the media described in the following sections. When necessary, antibiotics were used at the following concentrations: chloramphenicol (10 µg ml−1), kanamycin (15 µg ml−1), spectinomycin (100 µg ml−1), and tetracycline (5 µg ml−1). Gene deletions were constructed using long flanking homology PCR as previously described. Chromosomal DNA transformations were performed as described (Harwood and Cutting, 1990).
Table 1.
Strains used in this study
| Strain | Genotype | Plasmid | Source |
|---|---|---|---|
| CU1065 | W168 att SPβ trpC2 (wild type) | Laboratory stock | |
| HB11042 | CU1065 bshB2::spec | Gaballa et al., 2010 | |
| HB11069 | CU1065 glxB::kan | This work | |
| HB11079 | CU1065 bshC::kan | Gaballa et al., 2010 | |
| HB11212 | CU1065 bshC::mls | This work | |
| HB16505 | CU1065 glxA::cm | This work | |
| HB16506 | CU1065 khtU::tet | This work | |
| HB16507 | CU1065 glxA::cm bshC::kan | This work | |
| HB16513 | CU1065 glxC::cm | This work | |
| HB16515 | CU1065 glxC::cm bshC::kan | This work | |
| HB16520 | CU1065 yhdN::kan | This work | |
| HB16533 | CU1065 yhdN::kan bshC::mls | This work | |
| HB16544 | CU1065 glxB::kan bshC::mls | This work | |
| HB16545 | CU1065 glxA::cm glxB::kan | This work | |
| HB16546 | CU1065 khtU::tet glxB::kan | This work | |
| HB16547 | CU1065 | pMMB1309 | This work |
| HB16548 | CU1065 bshC::kan | pMMB1309 | This work |
| HB16549 | CU1065 glxB::kan | pMMB1309 | This work |
| HB16550 | CU1065 khtU::tet | pMMB1309 | This work |
| HB16551 | CU1065 yhdN::kan glxC::cm bshC::mls | This work | |
| HB16571 | CU1065 yraA::tet | This work | |
| HB16572 | CU1065 yfkM::spec | This work | |
| HB16573 | CU1065 yraA::tet yfkM::spec bshC::kan | This work | |
| HB16574 | CU1065 yraA::tet yfkM::spec ydeA::cm CU1065 yraA::tet yfkM::spec ydeA::cm |
This work | |
| HB16575 | bshC::kan | This work | |
| HB16576 | CU1065 yvgN::cm | This work | |
| HB16577 | CU1065 yccK::tet | This work | |
| HB16578 | CU1065 yqkF::cm | This work | |
| HB16579 | CU1065 yrpG::mls | This work | |
| HB16580 | CU1065 iolS::spec | This work | |
| HB16581 | CU1065 yvgN::cm yhdN::kan | This work | |
| HB16582 | CU1065 yccK::tet yhdN::kan | This work | |
| HB16583 | CU1065 yqkF::cm yhdN::kan | This work | |
| HB16584 | CU1065 yrpG::mls yhdN::kan | This work | |
| HB16585 | CU1065 iolS::spec yhdN::kan | This work |
Disk diffusion assays
Strains were grown in LB at 37°C with vigorous shaking to an OD600 ~0.4. A 100 µl aliquot of these cultures was added to 4 ml of LB soft agar (0.7% w/v agar) and poured on to prewarmed LB agar plates. The plates were then allowed to solidify for 10 minutes at room temperature in a laminar flow hood. Filter disks (0.6 mm) were placed on top of the agar and methylglyoxal (27.5 mmol) was added to the disks and allowed to absorb for 10 minutes. The plates were then incubated at 37C for 16–18 hours. The diameter of the zone of inhibition was measured.
Thiol quantification
For thiol analysis, the frozen cell pellets were derivatized with monobromobimane (mBBr) as previously described (Newton et al., 1981), with some alterations. Briefly, 20 µl of bimane mix (50% acetonitrile, 2mM mBBr, 20 mM HEPES pH 8.0) were added per milligram of estimated residual dry weight. The samples were incubated at 60 °C for 10 minutes in the dark, and then cooled on ice. To acidify the sample, 5 M methanesulfonic acid was added and the cell debris was removed by centrifugation. The cell pellet was dried in an oven at 60° C overnight and weighed the next day. The supernatant was subsequently filtered through a 0.22 µm membrane and diluted in 10 mM methanesulfonic acid for thiol quantification by analytical HPLC. HPLC was performed with a HiChrom ACE-AR C18 4.6×250 mm, 5 µm, 100Å column equilibrated at 37°C with 99% Solvent A (0.25% v/v acetic acid and 10% methanol, adjusted to pH 4 with NaOH) 1% Solvent B (90% methanol). Samples were eluted with a gradient of Solvent B with a 1.2 ml min−1 flow rate: 0–5 min, 1% B; 5–15 min, 0–20% B; and 15–20 min, 20–100% B, followed by re-equilibration and re-injection. The total acquisition running time was 32 minutes. Detection was carried out with 10x gain with a Jasco fluorescence detector with excitation at 385 nm and emission at 460 nm. The thiol quantification was based on the standard fluorescence at each run. Five hundred pmol of mBBr-labelled bacillithiol and cysteine standards were injected as quantified controls. Concentrations of BSH, expressed as µmol per gram dry weight, can be converted to an estimate of cytosolic concentrations by dividing by 3 as previously published (Newton et al., 2009).
Cytoplasmic pH measurements
Measurement of cytoplasmic pH was based on the method described previously (Kitko et al., 2009; Martinez et al., 2012). Strains containing pMMB1311, which encodes GFPmut3, were grown for 16–18 hours in modified M63 media (0.745 g l−1 KCl, 2 g l−1 casein hydrolysate, 2 g l−1 (NH42SO4, 0.4 g l−1 KH2PO4 and 0.4 g l−1 K2HPO4) buffered at pH 7 with (50 mM MOPS) to decrease background fluorescence with 5 µg ml−1 tetracycline. The cultures were then diluted in fresh M63 media and grown at 30°C with aeration to an OD600 ~0.4. Cells were then harvested by centrifugation, resuspended to an OD600 ~0.4 in modified M63 medium, and 3 ml of culture was transferred to a quartz cuvette (2 mm path length). Aeration was provided by stirring. GFPmut3 excitation was measured from 480 to 510 nm (slit width, 10 nm) and an emission wavelength of 545 nm (slit width 20 nm) using a Perkin Elmer LS55 Luminescence Spectrometer. For experiments in which MG was used, 1.5 mM MG was added to the cuvette at time 0.
Standard curves correlating internal pH with fluorescence intensity were generated by obtaining fluorescence measurements of cells resuspended at in 10 mM 3-(N-morpholino)propanesulfonic acid (MOPS) buffered at pH values of 6.3, 6.8, 7.4, and 7.7. The cytoplasmic pH was equilibrated with the external pH by addition of 10 µM nigericin, an ionophore that collapsed the pH across the membrane. An equation was fit to the signal intensity curve and used to extrapolate pH values from fluorescence measurements.
MG survival assays
Strains were grown in modified M63 media buffered with 50 mM MOPS pH 7 at 37 °C to an OD600 ~0.4. At time zero, MG was added to the culture at to a final concentration of 3 mM. At various time points after MG addition, aliquots of the culture were harvested by centrifugation, then washed and diluted with fresh M63 media. For experiments in which sodium benzoate was used, 30 mM sodium benzoate was added 5 min after MG addition. The cells were then spread on to LB plates and allowed to incubate for 16–18 hours at 37°C. Colonies were then counted and the percent survival was calculated as the number of colonies present with the addition of 3 mM MG divided by the number of colonies present without MG addition.
Acknowledgments
We thank the members of the Helmann lab for constructive comments and discussion. We also thank Dr. Ahmed Gaballa for strain construction and Dr. Joan Slonczewski for generously providing pMMB1309. This work was funded by a grant from the National Science Foundation to J.D.H. (NSF1020481). P.C. was supported in part by an NIH Postdoctoral Fellowship (1F32GM106729-01).
References
- Ackerman RS, Cozzarelli NR, Epstein W. Accumulation of toxic concentrations of methylglyoxal by wild-type Escherichia coli K-12. J Bacteriol. 1974;119:357–362. doi: 10.1128/jb.119.2.357-362.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bernat BA, Laughlin LT, Armstrong RN. Fosfomycin resistance protein (FosA) is a manganese metalloglutathione transferase related to glyoxalase I and the extradiol dioxygenases. Biochemistry. 1997;36:3050–3055. doi: 10.1021/bi963172a. [DOI] [PubMed] [Google Scholar]
- Booth IR. Regulation of cytoplasmic pH in bacteria. Microbiol Rev. 1985;49:359. doi: 10.1128/mr.49.4.359-378.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Booth IR, Ferguson GP, Miller S, Li C, Gunasekera B, Kinghorn S. Bacterial production of methylglyoxal: a survival strategy or death by misadventure? Biochem Soc Trans. 2003;31:1406–1408. doi: 10.1042/bst0311406. [DOI] [PubMed] [Google Scholar]
- Ehrensberger AH, Wilson DK. Structural and catalytic diversity in the two family 11 aldo-keto reductases. J Mol Biol. 2004;337:661–673. doi: 10.1016/j.jmb.2004.01.059. [DOI] [PubMed] [Google Scholar]
- Elmore MJ, Lamb AJ, Ritchie GY, Douglas RM, Munro A, Gajewska A, Booth IR. Activation of potassium efflux from Escherichia coli by glutathione metabolites. Mol Microbiol. 1990;4:405–412. doi: 10.1111/j.1365-2958.1990.tb00607.x. [DOI] [PubMed] [Google Scholar]
- Fang Z, Roberts AA, Weidman K, Sharma SV, Claiborne A, Hamilton CJ, Santos, Dos PC. Cross functionalities of Bacillus deacetylases involved in bacillithiol biosynthesis and bacillithiol-S-conjugate detoxification pathways. Biochem J. 2013 doi: 10.1042/BJ20130415. [DOI] [PubMed] [Google Scholar]
- Ferguson GP, Battista JR, Lee AT, Booth IR. Protection of the DNA during the exposure of Escherichia coli cells to a toxic metabolite: the role of the KefB and KefC potassium channels. Mol Microbiol. 35:113–122. doi: 10.1046/j.1365-2958.2000.01682.x. (200) [DOI] [PubMed] [Google Scholar]
- Ferguson GP, Booth IR. Importance of glutathione for growth and survival of Escherichia coli cells: detoxification of methylglyoxal and maintenance of intracellular K+ J Bacteriol. 1998;180:4314–4318. doi: 10.1128/jb.180.16.4314-4318.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ferguson GP, Munro AW, Douglas RM, McLaggan D, Booth IR. Activation of potassium channels during metabolite detoxification in Escherichia coli. Mol Microbiol. 1993;9:1297–1303. doi: 10.1111/j.1365-2958.1993.tb01259.x. [DOI] [PubMed] [Google Scholar]
- Fujisawa M, Wada Y. Modulation of the K+ efflux activity of Bacillus subtilis YhaU by YhaT and the C-terminal region of YhaS. FEMS Microbiology Letters. 2004;231:211–217. doi: 10.1016/S0378-1097(03)00959-5. [DOI] [PubMed] [Google Scholar]
- Fujisawa M, Ito M, Krulwich TA. Three two-component transporters with channel-like properties have monovalent cation/proton antiport activity. Proc Natl Acad Sci USA. 2007;104:13289–13294. doi: 10.1073/pnas.0703709104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gaballa A, Antelmann H, Hamilton CJ, Helmann JD. Regulation of Bacillus subtilis bacillithiol synthesis operons by Spx. Microbiology. 2013;159:2025–2035. doi: 10.1099/mic.0.070482-0. [DOI] [PubMed] [Google Scholar]
- Gaballa A, Newton GL, Antelmann H, Parsonage D, Upton H, Rawat M, et al. Biosynthesis and functions of bacillithiol, a major low-molecular-weight thiol in Bacilli. Proc Natl Acad Sci USA. 2010;107:6482–6486. doi: 10.1073/pnas.1000928107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Girgis HS, Harris K, Tavazoie S. Large mutational target size for rapid emergence of bacterial persistence. Proc Natl Acad Sci USA. 2012;109:12740–12745. doi: 10.1073/pnas.1205124109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Griffith R, Hammond EG. Generation of Swiss Cheese Flavor Components by the Reaction of Amino Acids with Carbonyl Compounds. Journal of Dairy Science. 1989;72:604–613. [Google Scholar]
- Harwood CR, Cutting SM. Molecular biological methods for Bacillus. New York: Wiley; 1990. [Google Scholar]
- Kelley LA, Sternberg MJE. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc. 2009;4:363–371. doi: 10.1038/nprot.2009.2. [DOI] [PubMed] [Google Scholar]
- Kitko RD, Cleeton RL, Armentrout EI, Lee GE, Noguchi K, Berkmen MB, et al. Cytoplasmic acidification and the benzoate transcriptome in Bacillus subtilis. PLoS ONE. 2009;4:e8255. doi: 10.1371/journal.pone.0008255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ko J, Kim I, Yoo S, Min B, Kim K, Park C. Conversion of methylglyoxal to acetol by Escherichia coli aldo-keto reductases. J Bacteriol. 2005;187:5782–5789. doi: 10.1128/JB.187.16.5782-5789.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Landmann JJ, Busse RA, Latz J-H, Singh KD, Stülke J, Görke B. Crh, the paralogue of the phosphocarrier protein HPr, controls the methylglyoxal bypass of glycolysis in Bacillus subtilis. Mol Microbiol. 2011;82:770–787. doi: 10.1111/j.1365-2958.2011.07857.x. [DOI] [PubMed] [Google Scholar]
- Lee C, Shin J, Park C. Novel regulatory system nemRA - gloA for electrophile reduction in Escherichia coli K-12. Mol Microbiol. 2013;88:395–412. doi: 10.1111/mmi.12192. [DOI] [PubMed] [Google Scholar]
- Lee JW, Soonsanga S, Helmann JD. A complex thiolate switch regulates the Bacillus subtilis organic peroxide sensor OhrR. Proc Natl Acad Sci USA. 2007;104:8743–8748. doi: 10.1073/pnas.0702081104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lei J, Zhou YF, Li LF, Su XD. Structural and biochemical analyses of YvgN and YtbE from Bacillus subtilis. Protein Sci. 2009;18:1792–1800. doi: 10.1002/pro.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leoncini G, Maresca M, Bonsignore A. The effect of methylglyoxal on the glycolytic enzymes. FEBS Lett. 1980;117:17–18. doi: 10.1016/0014-5793(80)80903-3. [DOI] [PubMed] [Google Scholar]
- MacLean MJ, Ness LS, Ferguson GP, Booth IR. The role of glyoxalase I in the detoxification of methylglyoxal and in the activation of the KefB K+ efflux system in Escherichia coli. Mol Microbiol. 1998;27:563–571. doi: 10.1046/j.1365-2958.1998.00701.x. [DOI] [PubMed] [Google Scholar]
- Marquardt T, Kostrewa D, Balakrishnan R, Gasperina A, Kambach C, Podjarny A, Winkler FK, Balendiran GK, Li XD. High-resolution crystal structure of AKR11C1 from Bacillus halodurans: and NADPH-dependent 4-hydroxy-2,3-trans-nonenal reductase. J Mol Biol. 2005;354:304–316. doi: 10.1016/j.jmb.2005.09.067. [DOI] [PubMed] [Google Scholar]
- Martinez KA, Kitko RD, Mershon JP, Adcox HE, Malek KA, Berkmen MB, Slonczewski JL. Cytoplasmic pH Response to Acid Stress in Individual Cells of Escherichia coli and Bacillus subtilis Observed by Fluorescence Ratio Imaging Microscopy. Appl Environ Microbiol. 2012;78:3706–3714. doi: 10.1128/AEM.00354-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Misra K, Banerjee AB, Ray S, Ray S. Reduction of methylglyoxal in Escherichia coli K12 by and aldehyde reductase and alcohol dehydrogenase. Mol Cell Biochem. 1996;156:117–124. doi: 10.1007/BF00426333. [DOI] [PubMed] [Google Scholar]
- Newton GL, Dorian R, Fahey RC. Analysis of biological thiols: derivatization with monobromobimane and separation by reverse-phase high-performance liquid chromatography. Anal Biochem. 1981;114:383–387. doi: 10.1016/0003-2697(81)90498-x. [DOI] [PubMed] [Google Scholar]
- Newton GL, Rawat M, La Clair JJ, Jothivasan VK, Budiarto T, Hamilton CJ, et al. Bacillithiol is an antioxidant thiol produced in Bacilli. Nat Chem Biol. 2009;5:625–627. doi: 10.1038/nchembio.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nguyen TTH, Eiamphungporn W, Mäder U, Liebeke M, Lalk M, Hecker M, et al. Genome-wide responses to carbonyl electrophiles in Bacillus subtilis: control of the thiol-dependent formaldehyde dehydrogenase AdhA and cysteine proteinase YraA by the MerR-family regulator YraB (AdhR) Mol Microbiol. 2009;71:876–894. doi: 10.1111/j.1365-2958.2008.06568.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ozyamak E, Black SS, Walker CA, Maclean MJ, Bartlett W, Miller S, Booth IR. The critical role of S-lactoylglutathione formation during methylglyoxal detoxification in Escherichia coli. Mol Microbiol. 2010;78:1577–1590. doi: 10.1111/j.1365-2958.2010.07426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ozyamak E, de Almeida C, de Moura APS, Miller S, Booth IR. Integrated stress response of Escherichia coli to methylglyoxal: transcriptional readthrough from the nemRA operon enhances protection through increased expression of glyoxalase I. Mol Microbiol. 2013;88:936–950. doi: 10.1111/mmi.12234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Papoulis A, al-Abed Y, Bucala R. Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product. Biochemistry. 1995;34:648–655. doi: 10.1021/bi00002a032. [DOI] [PubMed] [Google Scholar]
- Petersohn A, Antelmann H, Gerth U, Hecker M. Identification and transcriptional analysis of new members of the sigmaB regulon in Bacillus subtilis. Microbiology. 1999;145:869–880. doi: 10.1099/13500872-145-4-869. [DOI] [PubMed] [Google Scholar]
- Roberts AA, Sharma SV, Strankman AW, Duran SR, Rawat M, Hamilton CJ. Mechanistic studies of FosB: a divalent-metal-dependent bacillithiol-S-transferase that mediates fosfomycin resistance in Staphylococcus aureus. The Biochemical journal. 2013;451:69–79. doi: 10.1042/BJ20121541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rochat T, Nicolas P, Delumeau O, Rabatinová A, Korelusová J, Leduc A, et al. Genome-wide identification of genes directly regulated by the pleiotropic transcription factor Spx in Bacillus subtilis. Nucleic Acids Res. 2012;40:9571–9583. doi: 10.1093/nar/gks755. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Roosild TP, Castronovo S, Healy J, Miller S, Pliotas C, Rasmussen T, et al. Mechanism of ligand-gated potassium efflux in bacterial pathogens. Proc Natl Acad Sci USA. 2010;107:19784–19789. doi: 10.1073/pnas.1012716107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sakai A, Katayama K, Katusragi T, Tani Y. Glycoaldehyde-forming route in Bacillus subtilis in relation to vitamin B6 synthesis. J Biosci Bioeng. 2001;91:147–152. doi: 10.1263/jbb.91.147. [DOI] [PubMed] [Google Scholar]
- Subedi KP, Choi D, Kim I, Min B, Park C. Hsp31 of Escherichia coli K-12 is glyoxalase III. Mol Microbiol. 2011;81:926–936. doi: 10.1111/j.1365-2958.2011.07736.x. [DOI] [PubMed] [Google Scholar]
- Thompson MK, Keithly ME, Harp J, Cook PD, Jagessar KL, Sulikowski GA, Armstrong RN. Structural and chemical aspects of resistance to the antibiotic fosfomycin conferred by FosB from Bacillus cereus. Biochemistry. 2013;52:7350–7362. doi: 10.1021/bi4009648. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuber P, Chauhan S, Pilaka P, Nakano MM, Gurumoorthy S, Lin AA, et al. Phenotype enhancement screen of a regulatory spx mutant unveils a role for the ytpQ gene in the control of iron homeostasis. PLoS ONE. 2011;6:e25066. doi: 10.1371/journal.pone.0025066. [DOI] [PMC free article] [PubMed] [Google Scholar]






